Bio Roundup: RNAi Drama, Immunotherapy Data, Lasker Winners & More – Xconomy
Xconomy |
Bio Roundup: RNAi Drama, Immunotherapy Data, Lasker Winners & More
Xconomy From there, the week featured big headlines, both good and bad, from several trials in cancer immunotherapy, gene therapy, RNA interference, and much more. New companies joined the IPO queue. Others raised cash from private investors. And we haven't … |
